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INTRODUCTION
A petrous apex cholesterol granuloma (PACG) is a very com-
mon lesion of the petrous apex. Muckle et al. (1) reported hear-
ing loss as the most common symptom of petrous apex lesions,
followed by vestibular dysfunction, headache, tinnitus, facial
spasms, and diplopia. However, Castillo et al. (2) reported hea-
dache and facial nerve weakness as the most common symptoms,
and that most patients presented with more than one symptom.
Thus, there are no disease specific symptoms specific to PACG;
symptoms depend on the size and site of the PACG. Here, we
describe a case of PACG that manifested with a whirling- type
vertigo and fluctuating hearing loss, initially mistaken for Me@nie$re’s
disease.
CASE REPORT
A 32-yr-old, previously healthy man visited the International
Clinic of Asan Medical Center in May 2008, complaining of in-
termittent whirling-type vertigo. At that time, no obvious neu-
rological deficit or nystagmus was found on examination. Pre-
viously, he had been prescribed medication from other hospitals.
He took dimenhydrinate for about 2 weeks, but the vertigo wors-
ened. He was referred to our Department of Otolaryngology.
Each vertigo attack lasted about 10-15 min, and the episodes
occurred twice a month. In addition, he complained of right sided
tinnitus, a sense of ear fullness, and had a fluctuating hearing dis-
turbance. Both tympanic membranes were intact and otorrhea
was absent. Pure tone audiometry, speech audiometry, vestibu-
lar evoked myogenic potential (VEMP), electrocochleography,
and caloric testing, were planned, and a low-salt diet was rec-
ommended (3). 
Bone and air conduction values on the right side were 12 dB
and 15 dB, respectively, with up-sloping patterns. The cochlear
summating potential to auditory nerve action potential ratio (SP/
AP ratio) of the electrocochleogram was 0.43-0.56 (Fig. 1A) (4).
Video caloric testing demonstrated a right unilateral weakness
of 79% (Fig. 1B). The VEMP response was absent on the right
side (Fig. 1C). We diagnosed the patient with Me@nie$re’s disease
of the right side and prescribed ginkgo biloba extract and betahis-
tidine mesylate for 2 weeks. However, 4 days later the patient
presented to our emergency room because of muscle twitching
and numbness of the right side of the face. The patient was re-
ferred to a neurosurgeon. 
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A petrous apex cholesterol granuloma (PACG) is the most common lesion of the petrous apex mass. Affected patients
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Case ReportTo rule out a central neurological lesion, temporal bone mag-
netic resonance imaging (MRI) was performed. This showed a
2.5 cm lobulated mass at the right petrous apex. T1-weighted
MRI images showed a homogeneous, well-defined, high-intensi-
ty mass; T2-weighted images of the same lesion were heteroge-
neous and of high-intensity, but the area was not enhanced after
gadolinium administration (Fig. 2). These findings indicated the
presence of a PACG (5). To evaluate the bony structures and
assist in the plans for surgery, temporal bone computed tomog-
raphy (CT) was performed. This showed a 3 cm isodense mass
at the petrous apex, with thinning of the bony wall. After con-
sideration of the location of the cyst and the patient’s hearing
function as well as other possible complications such as contam-
ination of the cranial fossa by cholesterol material during and
after a middle fossa surgical approach, excision via an infralaby-
rinthine approach using a computer-aided image-guided surgi-
cal device (BrainLAB
�, Heimstetten, Germany) was performed
(6-8). 
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Fig. 1. (A) This electrocochleogram showed that the pati-
ent’s ratio of right cochlear summating potential to auditory
nerve action potential ratio (SP/AP ratio) was 0.43-0.56. (B)
Video caloric testing demonstrated a right unilateral weak-
ness of 79%. (C) Vestibular evoked myogenic potential (VE-
MP) response was absent on the right side.
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Fig. 2. Preoperative (A) T1-weighted, (B)
T2-weighted, and (C) T1-weighted images
with gadolinium-enhanced MRI scans sho-
wing a 2.5 cm-sized lobulating mass (ar-
row) at the right petrous apex. A B CA preoperative contrast-enhanced three-dimensional T1-weight-
ed MRI was conducted to allow installation of the surgical navi-
gation system. The patient’s head was fixed and three infrared
emitting markers (red dots) and pointers (green dots) were placed
(Fig. 3). The instrument recognized not only these markers, but
also the surface image of the patient. Paired-point and surface
matching were performed to compare the actual position of the
skull with the preoperative MRI imaging data. A complete mas-
toidectomy was performed, with skeletonization of the sigmoid
sinus. The mastoid segment of the facial nerve, posterior semi-
circular canal, and the jugular bulb, were identified. Using a dia-
mond burr, the infralabyrinthine air cell tract was followed an-
teromedially along the long axis of the temporal bone toward
the petrous apex. At the midpoint of the drilling process, a point-
er was used to confirm the relationship between the location of
the PACG and that of the drilling site (Fig. 3). Shining dark yel-
lowish material emerged from the puncture site (Fig. 4). After
suctioning the content of the cyst, a silastic drain was inserted
to drain any residue of the mastoid cavity.
Postoperatively, the patient did not complain of vertigo, hea-
dache, or facial palsy. There was no cerebrospinal fluid leakage
from the mastoid cavity. The patient was discharged from the
hospital on the sixth postoperative day. One month after sur-
gery, the results of the pure tone audiogram returned to the nor-
mal range (Fig. 5). A temporal bone CT scan revealed no aera-
tion at the petrous apex and the patient had no vertigo. The pa-
tient continued to visit the outpatient clinic for four months after
surgery, and remains well. Biopsy was confirmed as cholesterol
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Fig. 3. The computer-aided image-guided surgical device, BrainLAB
�.
Three infrared emitting fixed markers (red dots) and two pointers (green
dots) are seen in the right upper area of the screen.
Fig. 5. Pre- and post-operative pure tone audiometry (PTA). (A) Preoperative PTA showed decrease in the right hearing threshold at 0.25, 0.5,
and 4 kHz. (B) Postoperative PTA showed improvement at both the lower and higher tone hearing thresholds.
Fig. 4. Intraoperative findings. After a complete mastoidectomy, we
drilled a 1 cm-diameter hole through the petrous apex. This enabled
us to locate facial nerve anteriorly, the endolymphatic sac posteriorly,
the posterior semicircular canal superiorly, and the jugular bulb infe-
riorly. The cholesterol granuloma sac was exposed and dark yellow
color content was drained (arrow). 
FC: facial canal; JB: jugular bulb; PSCC: posterior semicircular canal.
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DISCUSSION
PACG is a reaction to a foreign body (cholesterol deposits).
Classically, the pathogenesis of PACG has been described as
being due to occlusion of the mastoid air cells. Absorption of
trapped air causes hemorrhage into the air cells and subsequent
degradation of accumulated hemosiderin to cholesterol, which
causes an inflammatory reaction and progressive granuloma for-
mation. Recently, a novel pathogenesis has been suggested; he-
morrhage from the exposed bone marrow of the hyper-pneu-
matized petrous apex is currently thought to be the etiology of
PACG (9). Treatment of a PACG is symptomatic or when there
are signs of a growing lesion. A variety of surgical approaches
are available to resect and drain the lesion, with stenting. To deter-
mine the optimal surgical approach, the patient’s hearing status,
the tumor size and the anatomical relationship between the tumor
location and the petrous apex bone, must be established. For a
deaf patient the translabyrinthine approach is preferred because
this provides good exposure. However, an infralabyrinthine ap-
proach is better if the hearing is to be preserved; however, this
approach is limited to patients with high jugular bulbs. The best
approach to prevent recurrence of a PACG is unclear. Giddings
recommended drainage for permanent aeration of a cholesterol-
based cyst, and observed that total removal was unnecessary
(10, 11). On the other hand, Eisenberg recommended complete
surgical extirpation with obliteration of the PACG cavity (12). 
CONCLUSION
PACG can be accurately diagnosed by CT and MRI if there are
clinical manifestations. However, a PACG may show no defini-
tive disease-specific symptoms or signs, because of the location
and size of the PACG. Therefore, the clinician must keep in mind
the possibility of a petrous apex lesion in patients that have the
clinical features of slowly aggravated endolymphatic hydrops.
Temporal bone MRI and CT scans aid in an accurate diagnosis.
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Fig. 6. Histopathology of the petrous apex cholesterol granuloma.
The cholesterol granuloma appeared as empty, irregularly shaped
clefts, or as spaces surrounded by a foreign body giant cell reaction;
fresh hemorrhage and hemosiderin pigment are apparent.